Preparation for potential participant
AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know. To learn more about AMR’s fully integrated network, click here:


What kind of preparation should a potential participant make for the meeting with the research coordinator or doctor?

  • February 21, 2011
  • Plan ahead and write down possible questions to ask.
  • Ask a friend or relative to come along for support and to hear the responses to the questions.
  • Bring a tape recorder to record the discussion to replay later.

Every clinical trial in the U.S. must be approved and monitored by an Institutional Review Board (IRB) to make sure

the risks are as low as possible and are worth any potential benefits. An IRB is an independent committee of

physicians, statisticians, community advocates, and others that ensures that a clinical trial is ethical and the

rights of study participants are protected. All institutions that conduct or support biomedical research involving

people must, by federal regulation, have an IRB that initially approves and periodically reviews the research.